Beneficial effects of erythropoietin in preclinical models of shock and organ failure
dc.contributor.author | Thiemermann, C | en_US |
dc.date.accessioned | 2016-05-26T11:37:11Z | |
dc.date.issued | 2007 | en_US |
dc.date.submitted | 2016-05-25T14:25:38.102Z | |
dc.identifier.issn | 1466-609X | en_US |
dc.identifier.other | 10.1186/cc5912 | |
dc.identifier.other | 132 | |
dc.identifier.other | 132 | en_US |
dc.identifier.other | 132 | en_US |
dc.identifier.other | 132 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/12541 | |
dc.description.sponsorship | William Harvey Research Foundation | en_US |
dc.format.extent | ? - ? | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | CRIT CARE | en_US |
dc.rights | CC0 1.0 Universal | |
dc.rights.uri | http://creativecommons.org/publicdomain/zero/1.0/ | |
dc.subject | RECOMBINANT-HUMAN-ERYTHROPOIETIN | en_US |
dc.subject | ISCHEMIA-REPERFUSION | en_US |
dc.subject | INJURY | en_US |
dc.subject | PROTECTS | en_US |
dc.subject | DISEASE | en_US |
dc.title | Beneficial effects of erythropoietin in preclinical models of shock and organ failure | en_US |
dc.type | Article | |
dc.rights.holder | 07 BioMed Central Ltd | |
dc.identifier.doi | 10.1186/cc5912 | en_US |
pubs.issue | 3 | en_US |
pubs.notes | Not known | en_US |
pubs.volume | 11 | en_US |